1 / 17

CHICKENPOX (VARICELLA)

CHICKENPOX (VARICELLA). VZV. The Varicella-Zoster Virus (VZV) belongs to the HERPES group. Pathogenic only for man; occurs worldwide . Causes 2 distinct clinical patterns: primary and latent.

ira-hooper
Download Presentation

CHICKENPOX (VARICELLA)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CHICKENPOX (VARICELLA) DR (MRS) M.B. FETUGA

  2. VZV • The Varicella-Zoster Virus (VZV) belongs to the HERPES group. • Pathogenic only for man; occurs worldwide . • Causes 2 distinct clinical patterns: primary and latent. • The primary infection is manifested as varicella (chickenpox) and results in establishment of a lifelong latent infection of sensory ganglion neurons. • The reactivated infections are known as herpes zosters (shingles). • It is predominantly a disease of childhood in tropical Africa. • Varicella is highly infectious in children. DR (MRS) M.B. FETUGA

  3. PATHOGENESIS 1 • Infection is spread by direct contact and by air droplets. • The virus may be contained in the pharyngeal secretions hence the infectivity via air droplets. • Patients are infectious for 2 days before the appearance of the rash and until the skin lesions have crusted although the crusts do not usually contain viable viruses. • The viruses gain entry via the mucosa of the conjunctivae, nasopharynx and URT. DR (MRS) M.B. FETUGA

  4. PATHOGENESIS 2 • Viral replication takes place at the point of entry and they invade through the local lymphatic and blood vessels resulting in viraemia. • At this stage, the viruses are seeded in the dorsal root ganglion cells where they remain dormant even after the acute infection has resolved. • Antibodies are formed which protect against re-infection but not against re-activation of latent infections. DR (MRS) M.B. FETUGA

  5. CLINICAL FEATURES OF VARICELLA • Diagnosis- clinical • VARICELLA begins usually SUDDENLY after an IP of 14 – 17 days. • Rash is usually accompanied by fever, malaise and pruritus. • Rash 1st appears on scalp & face and spreads to the trunk. Distribution is typically centripetal (more on the trunk than on the limbs; but spares hands & soles of feet). • Lesions begin as macules then turn to papules and vesicles. They crust within 2-3 days. DR (MRS) M.B. FETUGA

  6. Chickenpox rash with blisters, pustules & scabs DR (MRS) M.B. FETUGA

  7. CLINICAL FEATURES OF VARICELLA • New vesicles continue to appear over the first week of the illness. Typically, the rashes are present in different crops at the same time. • In Atypical form- the rash is not characteristic in appearance & distribution. The rash involves the flexural areas and concavities like the axillae, groin and mucous membranes of the nasopharnyx, conjunctivae & cornea. • Healing is usually complete although very minimal scarring may be present unlike in smallpox where scarring is massive. DR (MRS) M.B. FETUGA

  8. CLINICAL FEATURES OF VARICELLA • The rash involves the flexural areas and concavities like the axillae, groin and mucous membranes of the nasopharnyx, conjunctivae & cornea. • Healing is usually complete although very minimal scarring may be present. DR (MRS) M.B. FETUGA

  9. COMPLICATIONS OF VARICELLA • Generally benign in children with low mortality & few complications but may be fatal in neonates • Complications usually occur in debilitated and immunocompromised children, particularly those with: TB, severe malnutrition, Measles, HIV, malignancies and steroid therapy. • Secondary skin infection by Staphylococcus and Streptococcus. • CNS (due to post-infectious demyelination). e.g. encephalitis (cerebellar in form), polyneuritis, transverse myelitis and Reye syndrome. DR (MRS) M.B. FETUGA

  10. COMPLICATIONS OF VARICELLA • keratitis,conjunctivitis, carditis, appendicitis, glomerulonephritis, orchitis • DIC- thrombocytopenia DR (MRS) M.B. FETUGA

  11. CLINICAL FEATURES OF ZOSTER • Zoster is uncommon in childhood. • Early onset dx more likely to be ffged by herpes zoster due to persistence & prolonged presence of virus in the body • It is heralded by pain in the affected dermatome. • Few days later, the rash appears along the painful dermatome: typically, unilateral, segmental and proximal. • Any cranial or spinal sensory nerve may be affected but the thoracic nerves are most frequently affected. • The rashes are similar to those of varicella but are deeper and tend to heal with scarring. DR (MRS) M.B. FETUGA

  12. NEONATAL VARICELLA • Most babies acquire protective antibodies transplacentally, hence they are protected for the first 6 months of life (ONLY IF THE MOTHER PREVIOUSLY HAD THE INFECTION AND FORMED ANTIBODIES) • If a susceptible mother develops varicella rash 7 days or less before delivery, NEONATAL VARICELLA may occur in the baby. If the mother develops the rash more than 7 days before delivery, there is adequate time for the synthesis and transfer of antibodies against the virus. • Affected babies usually manifest 5-10 days after birth. • Mortality in Neonatal Varicella: 10 - 20%. DR (MRS) M.B. FETUGA

  13. CONGENITAL VARICELLA • Follows maternal varicella in the first 2 trimesters. • Xterised by multiple congenital anomalies including choroiditis and cerebral malformation. • Features include: skin scars, contractures, hypoplastic limb deformities with rudimentary digits, congenital cataract and microphthalmia. DR (MRS) M.B. FETUGA

  14. MANAGEMENT • Diagnosis is usually clinical. • Viral culture & serology may be done where facilities are available. • Treatment is largely symptomatic: calamine lotion to soothen the skin, oral antihistamines like promethazine and analgesia with paracetamol. • Secondary bacterial infection of skin lesions can be treated with topical silver sulphadiazine or chlorhexidine. Systemic antibiotics are only indicated when cellulitis occurs. • Post-exposure prophylaxis with IM Varicella-Zooster Immunoglobulin 2mL confers about 97% protection. • Clinical trials of a live attenuated vaccine are being done. DR (MRS) M.B. FETUGA

  15. PROGNOSIS • Recovery is ffged by long immunization. 2nd infection occasionally occurs DR (MRS) M.B. FETUGA

  16. PREVENTION • Vaccine - available, safe & effective. • Mainly used for children about to be treated with immunosuppressive drugs (leukemia) DR (MRS) M.B. FETUGA

  17. DIFFERENTIAL DIAGNOSIS • Impetigo, scabies, dermatitis multiforme DR (MRS) M.B. FETUGA

More Related